Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent - A phase II study of the EORTC early clinical trials group

Uta Bruntsch, Pierre Dodion, Wim W. Ten Bokkel Huinink, Heine H. Hansen, Herbert M. Pinedo, Mogens Hansen, Josette Renard, Martine Van Glabbeke

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent - A phase II study of the EORTC early clinical trials group'. Together they form a unique fingerprint.

Medicine & Life Sciences